Wei Guo
Affiliations: | Tsinghua University (Beijing), Beijing, Beijing Shi, China |
Area:
Neuroscience, Neurodegeneration, drug discoveryGoogle:
"Wei Guo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu H, Mei F, Ye R, et al. (2024) APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APP cerebral organoid model of Alzheimer's disease. Cell Research |
| Chu P, Guo W, You H, et al. (2023) Regulation of Satiety by -Expressing Neurons through TrkB Activation in Ventromedial Hypothalamus. Biomolecules. 13 |
| Qin X, Zhao Y, Zhang T, et al. (2022) TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice. Nature Communications. 13: 914 |
| Pang K, Jiang R, Zhang W, et al. (2021) An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments. Cell Research |
| Zhang L, Lin X, Wang T, et al. (2021) Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis. Bioresources and Bioprocessing. 8: 58 |
| Zhang SS, Xu JF, Sun XL, et al. (2021) Cellulomonas taurus sp. nov., a novel bacteria with multiple hydrolase activity isolated from livestock, and potential application in wastewater treatment. Antonie Van Leeuwenhoek |
| Zhang L, Guo W, Lu Y. (2020) Advances in Cell-Free Biosensors: Principle, Mechanism and Applications. Biotechnology Journal. e2000187 |
| Wang S, Yao H, Xu Y, et al. (2020) Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease. Theranostics. 10: 6854-6874 |
| You H, Chu P, Guo W, et al. (2020) A subpopulation of Bdnf-e1-expressing glutamatergic neurons in the lateral hypothalamus critical for thermogenesis control. Molecular Metabolism. 31: 109-123 |
| Guo W, Pang K, Chen Y, et al. (2019) TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration. Neurobiology of Disease. 104590 |